Congenital Heart Disease
Advances in the subspecialty of congenital heart disease (CHD) have greatly increased the survival of children so that larger numbers of adults with CHD are being encountered by adult cardiologists. It is found in about 1% of newborns and includes an array of structural heart defects, ranging from small holes between the chambers of the heart to transposition of the great vessels and missing or malformed heart chambers or valves. Some of the more complex cases, such as hypoplastic left heart syndrome and tetralogy of Fallot, will require multiple surgeries to manage as the child grows. Other CHD conditions include Ebstein’s anomaly, pulmonary atresia, tricuspid atresia, truncus arteriosus, atrial septal defect, atrioventricular canal, patent ductus arteriosus, ventricular septal defect, aortic coarctation, bicuspid aortic valve and pulmonary artery stenosis.
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](/sites/default/files/styles/top_stories/public/2024-09/istock-1209664264.jpg.webp?itok=gQInU1vO)
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](/sites/default/files/styles/240x220/public/2024-09/istock-1209664264.jpg.webp?itok=OEoT1RAi)
